Skip to content

BioNTech SE

BNTX· NasdaqCore metricsCIK 1776985

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -2.99%
Market cap
$21.50B
252.88M shares
Filings
590
€2.87B
FY 2025+4.3% FY25 yoy
-€1.14B
FY 2025N/M FY25 yoy
-€1.40B
FY 2025N/M FY25 yoy
€280.90M
FY 2025derivedN/M FY25 yoy
-€4.70
FY 2025N/M FY25 yoy
€7.68B
FY 2025−21.4% FY25 yoy
$21.50B
—
—
—
—
—

Price

$85.0421.73%$23.62past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

€2.87BFY 2025
€18.98B0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31€2,869,900,000reported
FY 20242024-12-31€2,751,100,000reported
FY 20232023-12-31€3,819,000,000reported
FY 20222022-12-31€17,310,600,000reported
FY 20212021-12-31€18,976,700,000reported
FY 20202020-12-31€482,300,000reported
FY 20192019-12-31€108,600,000reported
FY 20182018-12-31€127,575,000reported
FY 20172017-12-31€61,598,000reported

Capital returns

Dividends and buybacks · FY2020 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024€0.00—€0.00—239.97M sh+0.9%—
FY2023€0.00—€0.00—237.73M sh−1.4%0.0%
FY2022€484.30M—€484.30M—240.99M sh−2.4%3.7%
FY2021€0.00—€0.00—246.81M sh−99.9%0.0%
FY2020€0.00—€0.00—241.52B sh+6.5%—

Segments

Products
Cost of revenue by Products, FY2018 to FY2023FY2018Commercial revenues · FY2018 · €13.69MFY2019Commercial revenues · FY2019 · €17.40MFY2020Commercial revenues · FY2020 · €59.30MFY2021Commercial revenues · FY2021 · €2.91BFY2022Commercial revenues · FY2022 · €3.00BFY2023Omicron XBB.1.5-Adapted Monovalent COVID-19 Vaccine · FY2023 · €27.30M
LineFY2023ShareChange
Omicron XBB.1.5-Adapted Monovalent COVID-19 Vaccine€27.30M4.6%—
Commercial revenues———
Total€599.80M

From the 20-F filed Mar 20, 2024BNTX

Biological products, except diagnostic substances

BioNTech SE is the 7th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

BioNTech SE · CIK 1776985 · Engraved from SEC EDGAR